关注
Michael Daskalakis
Michael Daskalakis
Inselspital, University Hospital of Hematology, Freiburgstreet, 3010 Bern, Switzerland
在 insel.ch 的电子邮件经过验证
标题
引用次数
引用次数
年份
Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment
M Daskalakis, TT Nguyen, C Nguyen, P Guldberg, G Köhler, ...
Blood, The Journal of the American Society of Hematology 100 (8), 2957-2964, 2002
6882002
DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats
D Brocks, CR Schmidt, M Daskalakis, HS Jang, NM Shah, D Li, J Li, ...
Nature genetics 49 (7), 1052-1060, 2017
2922017
Telomerase inhibitor imetelstat in patients with essential thrombocythemia
GM Baerlocher, E Oppliger Leibundgut, OG Ottmann, G Spitzer, ...
New England Journal of Medicine 373 (10), 920-928, 2015
2122015
Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis
J Wilpert, KG Fischer, P Pisarski, T Wiech, M Daskalakis, A Ziegler, ...
Nephrology Dialysis Transplantation 25 (11), 3778-3786, 2010
1432010
Decitabine
M Daskalakis, N Blagitko-Dorfs, B Hackanson
Small Molecules in Oncology, 131-157, 2009
722009
Reactivation of endogenous retroviral elements via treatment with DNMT-and HDAC-inhibitors
M Daskalakis, D Brocks, YH Sheng, MS Islam, A Ressnerova, Y Assenov, ...
Cell Cycle 17 (7), 811-822, 2018
712018
Decitabine
B Hackanson, M Daskalakis
Small Molecules in Oncology, 269-297, 2014
592014
Decreased generation of procoagulant platelets detected by flow cytometric analysis in patients with bleeding diathesis
M Daskalakis, G Colucci, P Keller, S Rochat, T Silzle, FD Biasiutti, ...
Cytometry Part B: Clinical Cytometry 86 (6), 397-409, 2014
582014
Nonclonal neutrophil responses after successful treatment of myelodysplasia with low-dose 5-aza-2’-deoxycytidine (decitabine)
M Lübbert, M Daskalakis, R Kunzmann, M Engelhardt, Y Guo, ...
Leukemia research 28 (12), 1267-1271, 2004
442004
Comparison of different ribozymes for efficient and specific cleavage of BCR/ABL related mRNAs
W Lange, M Daskalakis, J Finke, G Dölken
FEBS letters 338 (2), 175-178, 1994
401994
Platelet transfusion induces alloimmunization to D and non-D Rhesus antigens
J Reckhaus, M Jutzi, S Fontana, VU Bacher, M Vogt, M Daskalakis, ...
Transfusion medicine and hemotherapy 45 (3), 167-172, 2018
312018
Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients
DA Sanoyan, K Seipel, U Bacher, MN Kronig, N Porret, G Wiedemann, ...
BMC cancer 23 (1), 345, 2023
232023
CAR T-cell persistence correlates with improved outcome in patients with B-cell lymphoma
V Wittibschlager, U Bacher, K Seipel, N Porret, G Wiedemann, ...
International journal of molecular sciences 24 (6), 5688, 2023
232023
Early use of corticosteroids following CAR T-cell therapy correlates with reduced risk of high-grade CRS without negative impact on neurotoxicity or treatment outcome
T Lakomy, D Akhoundova, H Nilius, MN Kronig, U Novak, M Daskalakis, ...
Biomolecules 13 (2), 382, 2023
232023
Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: a comparison between Swiss and American population-based cancer registries
S Benzarti, M Daskalakis, A Feller, VU Bacher, A Schnegg-Kaufmann, ...
Cancer epidemiology 59, 51-57, 2019
202019
Cytosine demethylation of the proteinase-3/myeloblastin primary granule protease gene during phagocyte development
M Lübbert, A Tobler, M Daskalakis
Leukemia 13 (9), 1420-1427, 1999
181999
DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts
A Goyal, J Bauer, J Hey, DN Papageorgiou, E Stepanova, M Daskalakis, ...
Nature communications 14 (1), 6731, 2023
172023
Platelet transfusion—insights from current practice to future development
A Capraru, KA Jalowiec, C Medri, M Daskalakis, SS Zeerleder, ...
Journal of clinical medicine 10 (9), 1990, 2021
162021
Azacitidine is effective for targeting leukemia-initiating cells in juvenile myelomonocytic leukemia
CF Krombholz, L Gallego-Villar, SS Sahoo, PK Panda, MW Wlodarski, ...
Leukemia 33 (7), 1805-1810, 2019
162019
Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party
O Penack, C Peczynski, C Koenecke, E Polge, A Kuhnl, N Fegueux, ...
Journal for immunotherapy of cancer 11 (4), 2023
142023
系统目前无法执行此操作,请稍后再试。
文章 1–20